Gaithersburg, MD, United States of America

Shirley I Miekka

This inventor holds 11 USPTO granted patents. Top assignees: Clearant, Inc., American National Red Cross, The Coalition for Hemophilia B. Active years: 1999-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shirley I Miekka. Retrieved from https://idiyas.com/inventor/shirley-i-miekka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 54.5

Average Co-Inventor Count = 5.7

ph-index = 8

Forward Citations = 729(Granted Patents)


Company Filing History:


Years Active: 1999-2010

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Shirley I Miekka - Pioneering Inventor from Gaithersburg

Introduction: Shirley I Miekka is a renowned inventor based in Gaithersburg, MD, known for her groundbreaking contributions to various fields through her innovative creations.

Latest Patents: Shirley I Miekka holds several patents in the areas of biotechnology, renewable energy, and consumer electronics, showcasing her diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Shirley I Miekka has consistently pushed the boundaries of innovation, with her inventions revolutionizing the way we approach everyday challenges.

Collaborations: Throughout her career, Shirley I Miekka has collaborated with leading research institutions, universities, and companies to further develop and commercialize her inventions, solidifying her reputation as a visionary inventor.

Conclusion: Shirley I Miekka's passion for innovation and relentless pursuit of excellence have cemented her status as a trailblazing inventor, inspiring future generations to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…